However, these conclusive findings coincide with clinical and experimental studies showing that enhanced FGF23 serum levels and/or the induction of cardiac FGF23 synthesis are not associated with high blood pressure-induced LVH (25, 34, 37). The gene discussed is FGF23; the disease is hypertensive disorder.